Location History:
- Saint Maur Des Fosses, FR (1994 - 1997)
- Paris, FR (1989 - 1999)
- Saint Maur, FR (1992 - 2001)
- La Rochelle, FR (2017 - 2018)
Company Filing History:
19 out of 25 
4 out of 48 
1 out of 15 
Years Active: 1989-2018
Title: Innovations and Contributions of Dominique Meyer in Pharmaceutical Formulations
Introduction: Dominique Meyer, an accomplished inventor based in Saint-Maur, France, has made significant contributions to the field of pharmaceutical formulations. With a remarkable portfolio of 24 patents, Meyer's expertise lies in developing innovative processes aimed at enhancing the efficacy and safety of contrast agents used in medical imaging.
Latest Patents: One of Meyer's latest patents focuses on a detailed process for preparing a liquid pharmaceutical formulation of contrast agents. This invention pertains to the utilization of a complex composed of macrocyclic chelate with a lanthanide. The formulation outlines the importance of maintaining specific concentrations of free macrocyclic chelate, optimizing its levels between 0.002% and 0.4%, with the preferred range set between 0.025% and 0.25%. The chelate compounds employed in this invention include DOTA, NOTA, DOTAGA, DO3A, BT-DO3A, HP-DO3A, and PCTA, ensuring precision and effectiveness in medical applications.
Career Highlights: Throughout his career, Dominique Meyer has worked with prominent organizations in the pharmaceutical industry, including Guerbet S.A. and Guerbet. His extensive experience has allowed him to spearhead innovative projects and contribute to advancements in medical imaging technologies.
Collaborations: In his professional journey, Meyer has collaborated with notable colleagues such as Michel Schaefer and Bruno Bonnemain. These partnerships have fostered a creative research environment that encourages the exchange of ideas and facilitates the development of groundbreaking pharmaceutical solutions.
Conclusion: Dominique Meyer's dedication to innovation in the pharmaceutical sector is evident through his extensive patent portfolio and collaborative efforts. His work on developing sophisticated processes for contrast agents not only enhances medical imaging but also showcases the importance of innovation in healthcare advancements.